Abstract
The major host defense mechanisms against bacterial overowth in the small bowel are the normal propulsive activity of the bowel itself and gastric acid secretion. Microbial interactions are a major factor in regulating the indigenous bacterial flora. Studies of the bacterial enzymes of the gut suggest that changes in diet may lead to marked changes in the colonic flora. Antibiotics affect the composition of the colonic microflora. The microflora also influence the degradation of mucin, the conversion of urobilin to urobilinogen, of cholesterol to coprostanol, and the production of short chain fatty acids. Current interests are focused on the bacterial flora of tropical sprue, the role of bacteria in colorectal cancer, and the involvement of intestinal microflora in the enterohepatic circulation of sex steroid hormones.
Similar content being viewed by others
References
Moore WEC, Holdeman LV: Discussion of current bacteriologic investigations of the relationships between intestinal flora, diet, and colon cancer. Cancer Res 35:3418–3420, 1975
Finegold S, Attebery HR, Sutter VL: Effect of diet on human fecal flora: Comparison of Japanese and American diets. Am J Clin Nutr 27:1456–1469, 1974
Drasar BS, Shiner M, Mcleod GM: Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 56:71–79, 1969
Gorbach SL, Plaut AG, Nahas L, Weinstein L: Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology 53:856–867, 1967
Drasar BS, Shiner M: Studies on the intestinal flora. II. Bacterial flora of the small intestine in patients with gastrointestinal disorders. Gut 10:812–819, 1969
Simon GL, Gorbach SL: Intestinal flora in health and disease. Gastroenterology 86:174–193, 1984
Justesen T, Nielsen OH, Jacobson IE, Lave J, Rasmussen SN: The normal cultivable microflora in upper jejeunal fluid in healthy adults. Scand J Gastroenterol 19:279–282, 1984
Hill MJ, Drasar BS: The normal colonic bacterial flora. Gut 16:318–323, 1975
Fitzgerald JF: Colonization of the gastrointestinal tract.In Selected Aspects of Perinatal Gastroenterology, Mead Johnson Symposium on Perinatal and Developmental Medicine 1977, pp. 35–38
Rotimi VO, Duerden BI: The bacterial flora in normal neonates. J med Micro 14:51–62, 1981
Long SS, Swenson RM: Development of anaerobic fecal flora in healthy newborn infants. J Pediatr 91:298–301, 1977
Gibbons RJ, Kapsimalis B: Estimates of the overall role of growth of the intestinal microflora of hamsters, guinea pigs and mice. J Bact 93:510–512, 1967
Dack GM, Petran E: Bacterial activity in different levels of the intestine and in isolated segments of small and large bowel in monkeys and dogs. J Infect Dis 54:204–220, 1934
Gorbach SL: Population control in the small bowel. Gut 8:530–532, 1967
Rolfe RD: Interactions among microorganisms of the indigenous intestinal flora and their influence on the host. Rev Inf Dis 67:S73-S59, 1984
Dixon JMS: The fate of bacteria in the small intestine. J Path Bact 79:131–140, 1960
Broido PW, Gorbach SL, Nyhus LM: Microflora of the gastrointestinal tract and the surgical malabsorption syndromes. Surg Gynecol Obstet 135:449–460, 1972
Drude RB Jr., Hines C Jr: The pathophysiology of intestinal bacterial overgrowth syndromes. Arch Intern Med 140:1349–1352, 1980
Gorbach SL, Tabaqchali S: Bacteria, bile, and the small bowel. Gut 10:963–972, 1969
King CE, Toskes PP: Small intestine bacterial overgrowth. Gastroenterol 76:1035–1055, 1979
Muscroft TJ, Deane SA, Youngs D, Burdon DW, Keighley MRB: The microflora of the postoperative stomach. Br J Surg 68:560–564, 1981
Enanker LK, Nilsson F, Ryden AC, Schwan A: The aerobic and anaerobic microflora of the gastric remnant more than 15 year after Billroth II resection. Scand J Gastroenterol 17:715–720, 1982
Cash R, Music S, Libonati J, Snder M, Wenzel R, Hornick R: Response of man to infection withV. cholerae. I. Clinical, serologic and bacteriologic response to a known inoculum. J Infect Dis 129:45–52, 1974
Mackowiak PA. The normal microbial flora. N Engl J Med 307:83–93, 1982
Savage DC: Microbial ecology of the gastrointestinal tract. Ann Rev Microbiol 31:107–133, 1977
Wolin MJ: Metabolic interactions among intestinal microorganisms. Am J Clin Nutr 27:1320–1328, 1974
Freter R: In-vivo and in-vitro antagonism of intestinal bacteria againstShigella flexneri II. The inhibitory mechanism. J Inf Dis 110:38–46, 1962
Byrne BM, Dankert J: Volatile fatty acids and aerobic flora in the gastrointestinal tract of mice under various conditions. Infect Immun 23:559–563, 1979
Hentges DJ, Maier BR: Inhibition ofShigella flexneri by the normal intestinal flora. III. Interactions withBacteroides fragilis strains in vitro. Infect Immun 2:364–370, 1970
Luckey TD: Bicentennial overview of intestinal microecology. Am J Clin Nutr 30:1753–1761, 1977
Kelstrup J, Gibbons RJ: Inactivation of bacteriocins in the intestinal canal and oral cavity. J Bacteriol 99:888–890, 1969
Gorbach SL, Nahas L, Lerer PI, Weinstein L: Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterol 53:845–855, 1967
Gorbach SL: The effect of diet on the intestinal microflora and its metabolic functions.In Defined Formula Diets for Medical Purposes, ME Shils (ed). Am Med Assoc, Chicago, 1977
Attebery HR, Sutter VL, Finegold SM: Effect of a partially chemically defined diet on normal human fecal flora. Am J Clin Nutr 1391–1398, 1972
Bornside GH, Cohn Jr, I: Stability of normal human fecal flora during a chemically defined, low residue liquid diet. Ann Surg 181:58–60, 1974
Drasar BS, Jenkins DJA, Cummings JH: The influence of a diet rich in wheat fiber on the human fecal flora. J Med Microb 9:423–431, 1976
Hentges DJ: Fecal flora of volunteers on controlled diets. Am J Clin Nutr 31:S123-S124, 1978
Hill MJ, Drasar BS, Aries V, Crowther JS, Hawksworth G, Williams REO: Bacteria and aetiology of cancer of large bowel. Lancet 1:95–100, 1971
Finegold SM, Sutter VL: Fecal flora in different populations, with special reference to diet. Am J Clin Nutr 31:S116-S122, 1978
Finegold SM, Sutter VL, Sugihara PT, Elder HA, Lehmann SM, Phillips RL: Fecal microbial flora in Seventh Day Adventist populations and control subjects. Am J Clin Nutr 30:1781–1792, 1977
Bartlett JG, Condon RE, Gorbach SL, Clarke JS, Nichols RL, Ochi S: Veterans Administration cooperative study on bowel preparation for elective colorectal operations: Impact of oral antibiotic regimen on colonic flora, wound irrigation cultures and bacteriology of septic complications. Ann Surg 188:249, 254 1978
Gorbach SL, Spanknebel G, Weinstein L, Plaut AG, Nahas L, Levitan R: Studies of intestinal microflora. VIII. Effect of lincomycin on the microbial population of the human intestine. J Infect Dis 120:298–304, 1969
Nordenvall B, Hallberg D, Larsson L, Nord CE: The effect of clindamycin on the intestinal flora in patients with enteic hyoperoxaluria. Scand J Gastroenterol 18:177–181, 1983
Clarke JS, Condon RE, Bartlett JG, Gorbach SL, Nichols RL, Ochi S: Preoperative oral antibiotics reduce septic complications of colon operations: Results of prospective, randomized, double-blind clinical study. Ann Surg 186:251–259, 1977
Nichols RL, Broido P, Condon RE, Gorbach SL, Nyhus LM: Effect of preoperative neomycin-erythromicin intestinal preparation on the incidence of infectious complications following colon cancer. Ann Surg 178:453–462, 1973
Dion YM, Richards GK, Prentis JJ, Hinchey EJ: The influence of oral versus parenteral preoperative metronidazole on sepsis following colon surgery. Ann Surg 192:221–226, 1980
Schimpff SC, Young VM, Greene WH, Vermeulen GD, Mood MR, Wiernik PH: Origin of infection in acute nonlymphocytic leukemia: Significance of hospital acquisition of potential pathogens. Ann Intern Med 77:707–714, 1972
Guiot HFL, van den Broek PJ, van der Meer JWM, van Furth R: Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: A double-blind, placebo-controlled study. J Inf Dis 147:615, 1983
Gurwith MJ, Brunton JL, Lank BA, Harding GKM, Ronald AR: A prospective controlled investigation of prophylactic trimethorpim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 66:248–256, 1979
Schimpff SC, Greene WH, Young VM, Fortner CL, Jepsen L, Cusack N, Block JB, Wiernik PH: Infection prevention in acute nonlymphocytic leukemia: Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med 82:351–358, 1975
Sleijfer DT, Mulder NH, de Vries-Hospers HG, Fidler V, Nieweg HO, van der Waaij D, van Saene HKF: Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Europ J Cancer 16:859–869, 1980
Wade JC, Schimpff SC, Hargadon MS, Fortner CL, Young VM, Wiernik PH: A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 304:1057–1062, 1981
Schimpff SC: Infection prevention during profound granulocytopenia. Ann Inten Med 93:358–361, 1981
Guiot HFL, van der Meer JWM, van Furth R: Selective antimicrobial modulation of human microbial flora: Infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Inf Dis 143:644–654, 1981
Van der Waaij D, De Vries JM, Ledderkerk JEC: Colonization resistance of the digestive tract in conventional and antibiotic treated mice. J Hygiene 9:405, 1971
Kurpad AV, Shetty PS: Effects of antimicrobial therapy of fecal bulking. Gut 27:55–58, 1986
Plaa GL: The enterohepatic circulation.In Handbook of Experimental Pharmacology. JR Gillete (ed). New York, Springer-Verlag, 1975
Scheline RR: Metabolism of foreign compounds by gastrointestinal microorganisms. Pharm Rev 25:451–523, 1973
Lindenbaum J, Rund DG, Butler Jr. VP, Tse-Eng D, Saha JR: Inactivation of digoxin by the gut flora: Reversal by antibiotic therapy. N Engl J Med 305:789–794, 1982
Dobkin JF, Saha JR, Butler Jr VP, Neu HC, Lindenbaum J: Inactivation of digoxin by Eubacterium lentum, an anerobe of the human gut flora. Clin Res 30:551A, 1982
Abrams GD, Bauer H, Sprinz H: Influence of the normal flora on mucosal morphology and cellular renewal in the ileum. A comparison of germ-free and conventional mice. Lab Invest 12:355–364, 1963
Coates ME, Fuller B: The gnotobiotic animal in the study of gut microbiology.In Microbial Ecology of the Gut, RTJ Clarke, T Bauchop (eds). New York, Academic Press, 1977, 311–346
Thompson GR, Trexler PC: Gastrointestinal structure and function in germ-free or gnotobiotic animals. Gut 12:230–235, 1971
Gordon HA, Bruchorer-Kardoss E: Effect of normal microbial flora on intestinal surface area. Am J Physiol 201:175–182, 1961
Lesher S, Walburg HE, Sacher GA: Generation cycle in the duodenal crypt cells of germ free and conventional mice. Nature 202:884–886, 1964
Kenworthy R: Observations on the reaction of the intestinal mucosa to bacterial challenge. J Clin Pathol 24:138–145, 1971
Gordon HA:In The Germfree Animal in Research, ME Coates (ed). New York, Academic Press, 1968, 127–150
Abrams GD: Microbial effects on mucosal structure and function. Am J Clin Nutr 30:1880–1886, 1977
Henegan JB: Influence of microbial flora on xylose absorption in rats and mice. Am J Physiol 205(3):417–420, 1963
Bergstrand LO, Gustaffson BE, Holmstrum B, Norin KE: the physiological activity of human fecal flora evaluated by determination of germfree animal characteristics. Acta Chir Scand 147:703–705, 1981
Norin KE, Gustaffson BE, Lindblad BS, Midtvedt T: The establishment of some microflora associated biochemical characteristics in feces from children during the first year of life. acta Periatr Scand 74:207–212, 1985
Midtvedt T, Carlstedt-Duke B, Hoverstad T, Lingaas E, Norin KE, Saxerholt H, Steinbakk M: Influence of peroral antibiotics upon the biotransformatory activity of the intestinal microflora in healthy subjects. (In press.)
Cohen R, Kalser MH, Arteaga I, Yawn E, Frazier D, Leite CA, Ahearn DG, Roth F: Microbial intestinal flora in acute diarrheal disease. JAMA 201: 835–840, 1967
Gorbach SL, Banwell JG, Chatterjee BD, Jacobs B, Sack RB: Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal microflora. J Clin Invest 50:881–889, 1971
Gorbach SL, Banwell JG, Jacobs B, Chatterjee BD, Mitra R, Brigham KL, Neogy KN: Intestinal microflora in Asiatic cholera. I. “Rice-water” stool. J Infect Dis 121:32–37, 1970
Gorbach SL, Banwell JG, Jacobs B, Chatterjee BD, Mitra R, Brigham KL, Neogy KN: Intestinal microflora in Asiatic cholera. II. The small bowel. J Infect Dis 121:38–45, 1970
Gorbach SL, Kean BH, Evans DG, Evans Jr., DJ, Bessudo D: Travelers' diarrhea and toxigenicEscherichia coli. N Engl J Med 292:933–936, 1975
Gorbach SL, Khurana CM: ToxigenicEscherichia coli. A cause of infantile diarrhea in Chicago. N Engl J Med 287:791–795, 1972
Guerrant RL, Moore RA, Kirschenfeld PM, Sande MA: Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med 293:567–573, 1975
Merson MH, Morris GK, Sack DA, Wells JG, Feeley JC, Sack RB, Creech WB, Kapikian AZ, Gangarosa EJ: Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a Congress. N Engl J Med 294:1299–1304, 1976
Ryder RW, Wachsmuth K, Buxton AE, Evans DG, DuPont HL, Mason E, Barrett FF: Infantile diarrhea produced by heat-stabile enterotoxigenicEscherichia coli. N Engl J Med 295:849–853, 1976
Gorbach SL, Neale G, Levitan R, Hepner GW: Alterations in human intstinal microflora during experimental diarrhea. Gut 11:1–6, 1970
Hill ID, Mann MD, Moore L, Bowie MD: Duodenal microflora in infants with acute and persistent diarrhea. Arch Dis Child 38:330–334, 1985
Cushing AH, Smart J: Gastrointestinal carriage of toxigenic bacteria: Relation to diarrhea and to serum immune response. P Inf Dis 151:114–123, 1985
Echeverria P, Louria CJ, Smith AL, Smith D: Variations in enterotoxigenicity of E. coli. J Inf Dis 135:195–200, 1977
Bartlett JG, Chang T-W, Taylor NS, Onderdonk AB: Colitis induced byClostridium difficile. Rev Infect Dis 1:370–378, 1976
Bartlett JG, Chang T-W, Gurwith M, Gorbach SL, Onderdonk AB: Antibiotic-associated Pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 298:531–534, 1978
Ruddell WSJ, Axon ATR, Findlay JM, Bartholomew BA, Hill MJ: Effect of cimetidine on the gastric bacterial flora. Lancet i:672–674, 1980
Bjorneklett A, Fausa O, Midtvedt T: Small bowel bacterial overgrowth in the post gastrectomy syndrome. Scand J Gastroenterol. 18:277–287, 1983
Browning GG, Buchan KA, Mackay C: The effect of vagotomy and drainage on the small bowel flora. Gut 15:139–142, 1974
Greenlee HB, Gelbart SM, DeOrio AJ, Francescatti DS, Paez J, Reinhardt GF: The influence of gastric surgery on the intestinal flora. Am J Clin Nutr 30:1826–1833, 1977
Deane S, Youngs D, Poxon V, Keighley MRB, Alexander-Williams J, Burdon DW: Cimetidine and gastric microflora. Brit J Surg 67:371, 1980
Muscroft TJ, Youngs D, Burdon DW, Keighley MRB. Cimetidine and the potential risk of postoperative sepsis. Br J Surg 68:557–559, 1982
Snepar R, Poporad GA, Romana JM, Kobasa WD, Kaye D: Effect of cimetidine and antacid on gastric microbial flora. Infect Immun 36:518–524, 1982
Ruddell WSJ, Losowsky MS: Severe diarrhea due to small intestinal colonization during cimetidine treatment. Brit Med J 3:273, 1980
Gracey M, Suharjono S, Stone DE: Microbial contamination of the gut. Another feature of malnutrition. Am J Clin Nutr 26:1170–1174, 1973
Ament ME, Shimoda SS, Saunders DR, Rubin CE: Pathogenesis of steatorrhea in three cases of small intestinal stasis syndrome. Gastroenterol 63:728–747, 1970
Goldstein F, Wirts CW, Kowlessar OD: Diabetic diarrhea and steatorrhea. Microbiologic and clinical observations. Ann Intern Med 72:215–218, 1970
Gorbach SL, Lal D, Levitan R: Intestinal microflora in Laennec's cirrhosis. J Clin Invest 49:36a, 1970
Maldonado JE, Gregg JA, Green PS, Brown AL: Chronic idiopathic intestinal pseudoobstruction. Am J Med 49:203–212, 1970
Whalen GE, Soergel KH, Geenen JE: Diabetic diarrhea. Gastroenterol 56:1021–1032, 1969
Goldstein F, Cozzolino HJ, Wirts CW: Diarhea and Steatorrhea due to a large solitary duodenal diverticulum. Am J Dig Dis 8:937, 1963
McEvoy A, Dutton J, James OFW: Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly. Brit Med J 287:789–793, 1983
Robert SH, James O, Jarvis EH: Bacterial overgrowth syndrome without “blind loop”: A cause for malnutrition in the elderly. Lancet 2:1193–1195, 1977
Polter DE, Boyle JD, Miller LG, Finegold SM: Anaerobic bacteria as cause of the blind loop syndrome. A case report with observations on response to antibacterial agents. Gastroenterol 54:1148–1154, 1968
Dawson AM, Isselbacher KJ: Studies of lipid metabolism in the small intestine with observation on the role of bile salts. J Clin Invest 39:730–740, 1960
Donaldson Jr, RM: Studies on the pathogenesis of steatorrhea in the blind loop syndrome. J Clin Invest 44:1815–1825, 1965
Gracey M: The contaminated small bowel syndrome: pathogenesis, diagnosis, and treatment. Am J Clin Nutr 32:234–243, 1979
Isaacs ET, Kim S: The contaminated small bowel syndrome. Am J Med 67:1049–1057, 1979
Kim YS, Spritz N, Blum M, Terz J, Sherlock P: The role of altered bile acid metabolism in the steatorrhea of experimental blind loop. J Clin Invest 45:956–962, 1966
Drasar BS, Hill MJ, Shiner M: The deconjugation of bile salts by human intestinal bacteria. Lancet 1237–1238, 1966
Aries V, Crowther JS, Drasar BS, Hill MJ: Degradation of bile salts of human intestinal bacteria. Gut 10:575–576, 1969
Lewis R, Gorbach S: Modification of bile acids by intestinal bacteria. Arch Intern Med 130:545–548, 1972
Donaldson Jr, RM: Malabsorption of60Co-labeled cyanocobalamin in rats with intestinal diverticula. I. Evolution of possible mechanisms. Gastroenterol 43:271–281, 1962
Donaldson Jr, RM, Corrigon H, Natsios G: Malabsorption of60Co-labeled cyanocobalamin in rats with intestinal diverticula. II. Studies on contents of the diverticula. Gastroenterol 43:282–290, 1962
Giannella RA, Broitmen SA, Zamcheck N: Vitamin B12 uptake by intestinal microorganisms: Mechanism and relevance to syndromes of intestinal bacterial overgrowth. J Clin Invest 50:1100–1107, 1971
Schjonsby H, Peters TJ, Hoffbrond AV, Tabaqchali S: The mechanism of vitamin B12, malabsorption in the blind loop syndrome. Gut 11:37, 1970 (abstr.)
Welkos S, Toskes P, Baer H: Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome. Gastroenterol 80:313–320, 1981
Aarbakke J, Schjonsby H: Value of urinary simple phenol and indican determinations in the diagnosis of the stagnant loop syndrome. Scand J Gastroenterol 11:409–414, 1976
Goldstein F, Karacadag S, Wirts CW, Kowlessar OD: Intraluminal small-intestinal utilization of d-xylose by bacteria. A limitation of the d-xylose absorption test. Gastroenterol 59:380–386, 1970
Chernov AJ, Doe WF, Gompertz D: Intrajejunal volatile fatty acids in the stagnant loop syndrome. Gut 13:103–106, 1972
Prizont R, Whitehead JS, Kim YS: Short chain fatty acids in rats with jejeunal blind loops. I. Analysis of SCFA in small intestine, cecum, feces, and plasma. Gastroenterol 69:1254–1264, 1975
Toskes PP, Giannella RA, Jervis HR, Rout WR, Takeuchi A: Small intestinal mucosal injury in the experimental blind loop syndrome. Gastroenterol 68:1193–1203, 1975
Giannella RA, Rout WR, Toskes PP: Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterol 67:965–974, 1974
Gracey M, Papadimitriou J, Bower G: Ultrastructural changes in the small intestines of rats with self-filling blind loops. Gastroenterol 67:646–651, 1974
Gracey M, Thomas J, Houghton M: Effect of stasis on intestinal enzyme activities. Aust NZ J Med 5:141–144, 1975
Jonas A, Flanagan PR, Forstner GG: Pathogenesis of mucosal injury in the blind loop syndrome. Brush border enzyme activity and glycoprotein degradation. J Clin Invest 60:1321–1330, 1977
Jonas A, Krishnan C, Forstner G: The role of unconjugated bile salts and bacterial proteins as causes of mucosal injury in the contaminated bowel syndrome. Gastroenterol 72:1076, 1977, (Abstr)
Riepe SP, Goldstein J, Alpers DH: Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases. J Clin Invest 66:314–322, 1980
Klipstein GA: Tropical sprue. Gastroenterol 1:946–949, 1968
Klipstein FA: Recent advances in tropical malabsorption. Scand J Gastroenterol Suppl 6:93–114, 1970
Cook GC: Tropical sprue: Implications of Manson's concept. J Roy Coll Phys 12:329–349, 1978
Mathan VI, Baker SJ: Epidemic tropical sprue and other epidemics of diarrhea in south Indian villages. Am J Clin Nutr 21:1077–1087, 1968
Bhat P, Shantakumari S, Rajan D, Mathan VL, Kapadia CR, Swarnabai C, Baker SJ: Bacterial flora of the gastro-intestinal tract in Southern Indian control subjects and patients with tropical sprue. Gastroenterol 62:11–21, 1972
Gorbach SL, Banwell JG, Jacobs B, Chatterjee BD, Mitra R, Sen NN, Guha Mazumder DN: Tropical sprue and malnutrition in West Bengal. I. Intestinal microflora and absorption. Am J Clin Nutr 23:1545–1558, 1970
Gorbach SL, Mitra R, Jacobs B, Banwell JG, Chatterjee BD, Guha Mazumder DN: Bacterial contamination of the upper small bowel in tropical sprue. Lancet 1:74–77, 1969
Tomkins AM, Drasar BS, James WPT: Bacterial colonization of jejunal mucosa in acute tropical sprue. Lancet i:59–61, 1975
Klipstein FA, Holdeman LV, Corcino JJ, Moore WEC: Enterotoxigenic intestinal bacteria in tropical sprue. Ann Intern Med 79:632–641, 1973
Klipstein FA, Goetsch CA, Engert RF, Short HB, Schenk EA: Effect of monocontamination of germfree rats by enterotoxigenic coliform bacteria. Gastroenterol 79:341–348, 1979
Banwell JG, Gorbach SL, Mitra R, Cassells JS, Guha Mazumder DN, Thomas J, Hardley JH: Tropical sprue and malnutrition in West Bengal. II. Fluid and electrolyte transport in the small intestine. Am J Clin Nutr 21:1559–1568, 1970
Banwell JG, Gorbach SL: Tropical sprue. Gut 10:328–333, 1969
Gerson CD, Kent TH, Saha Jr, Siddiqi N, Lindenbaum J: Recovery of small-intestinal structure and function after residence in the tropics. II. Studies in Indians and Pakistanis living in New York City. Ann Intern Med 75:41–48, 1971
Cook GC: Aetiology and pathogenesis of postinfective tropical malabsorption (tropical sprue). Lancet i:721–723, 1984
Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries, with special references to dietary practices. Int J Cancer 15:617–631, 1975
Burkitt DP: Epidemiology of cancer of the colon and rectum. Cancer 28:3–13, 1971
Doll R: The geographical distribution of cancer. Br J Cancer 23:1–8, 1969
Drasar BS, Irving D: Environmental factors and cancer of the colon and breast. Br J Cancer 27:167–172, 1973
Reddy BS, Mastromarino A, Wynder EL: Further leads on metabolic epidemiology of large bowel cancer. Cancer Res 35:3403–3406, 1975
Wynder EL: The epidemiology of large bowel cancer. Cancer Res 35:3388–3394, 1975
Wynder EL, Kajitani T, Ishikawa S, Dodo H, Takano A: Environmental factors of cancer of the colon and rectum. Cancer 23:1210–1220, 1969
Crowther JS, Drasar BS, Hill MJ, MacLennan R, Magnin D, Peach S, Teoh-Chan CH: Faecal steroids and bacteria and large bowel cancer in Hong Kong by socioeconomic groups. J Cancer 34:191–198, 1976
Haenszel R, Berg JW, Segi M, Kurihara M, Locke FB: Large-bowel cancer in Hawaiian Japanese. J Natl Cancer Inst 51:1765–1779, 1973
Drasar BS, Jenkins DJA: Bacteria, diet and large bowel cancer. Am J Clin Nutr 29:1410–1416, 1976
Hill MJ: Diet and the human intestinal bacterial flora. Canc Res 41:3778–3780, 1981
Vargo D, Moskovitz M, Floch MH: Faecal bacterial flora in cancer of the colon. Gut 21:701–705, 1980
Hill MJ: The role of colon anaerobes in the metabolism of bile acids and steroids, and its relation to colon cancer. Cancer 36:2387–2400
Weisburger JH: Colon carcinogens: Their metabolism and mode of action. Cancer 28:60–70, 1971
Goldin BR, Gorbach SL: The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J Natl Cancer Inst 57:371–375, 1976
Laqueur GL, Mickelson O, Whiting MG, Kurland LT: Carcinogenic properties of nuts from Cyclos circonilis. J Natl Cancer Inst 31:919–951, 1963
Laqueur GL, Spatz M: Toxicology of cycasin. Cancer Res 28:2262–2267, 1968
Laqueur GL: The induction of intestinal neoplasia with the glycoside of cycasin and its aglycone. Virchow Arch Path Anat 340:151–163, 1965
Laqueur GL, McDaniel EG, Matsumoto H: Tumor induction in germfree rats with methylazoxymethanol (MAM) and synthetic MAM acetate. J Natl Cancer Inst 39:355–371, 1967
Hill MJ: Bacteria and the etiology of colonic cancer. Cancer 34:815–818, 1974
Hill MJ, Drasar BS, Williams REO: Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet i:535–538, 1975
Kay RM: Effects of diet on the fecal excretion and bacterial modification of acidic and neutral steroids, and implications for colon carcinogenesis. Cancer Res 42:3774–3777, 1981
Mastromarino A, Reddy BS, Wynder EL: Metabolic epidemiology of colon cancer: enzymic activity of fecal flora. Am J Clin Nutr 29:1455–1460, 1976
Mower HF, Ray RM, Shoff R, Stemmermann GN, Nomura A, Glober GA, Kamiyama S, Shimada A, Yamakawa H: Fecal bile acids in two Japanese populations with different colon cancer risks. Cancer Res 39:328–331, 1979
Reddy BS, Wynder EL: Large-bowel carcinogenesis: Fecal constituents of populations with diverse incidence rates of colon cancer. J Natl Cancer Inst 50:1437–1442, 1973
White BA, Lipsky RL, Fricke RJ, Hylemon PB: Bile acid induction specificity of 7-alpha-dehydroxylase activity in an intestinalEubacterium species. Steroids 35:103–109, 1980
Hill MJ: Bile, bacteria and bowel cancer. Gut 24:871–875, 1983
Wilpart M, Mainguet P, Maskens A, Roberfroid M: Mutagenicity of 1,2-dimethylhydrazine towardsSalmonella typhimurium, co-mutagenic effect of secondary bile acids. Carcinogenesis 4:45–48, 1983
Weisburger JH, Grantham PM, Horton RE, Weisburger EK: Metabolism of the carcinogen N-hydroxy-N-2-fluorenyl-acetamide in germ free rats. Biochem Pharmacol 19:151–162, 1970
Fischer LJ, Millburn P, Smith RL, Williams RT: The fate of (14C) stilboestriol in the rat. Biochem J 100:698, 1966
Granthame PH, Horton RE, Weisberger EK, Weisberger JH: Metabolism of the carcinogen N-2-fluoroenylacetamide in germ free and conventional rats. Biochem Pharmacol 19:163–171, 1976
Reddy BS, Weisburger JH, Wynder EL: Fecal bacterial beta-glucuronidase: Control by diet. Science 183:416–417, 1974
Gillette JR, Kamm JJ, Sasame HA: Mechanism of p-nitrobenzoate reduction in mice: The possible role of cytochrome P-450 in liver microsomes. Mol Pharmacol 4:541–548, 1968
Kato R, Oshima R, Takanara A: Studies on the mechanism of nitro reduction by rat liver. Mol Pharmacol 5:487–494, 1962
Weisburger JH, Weisburger EK: Biochemical, formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acid. Pharmacol Rev 25:1, 1973
Goldin B, Dwyer J, Gorbach SL, Gordon W, Swenson L: Influence of diet and age on fecal bacterial enzymes. Am J Clin Nutr 31:S136-S140, 1978
Goldin BR: The role of diet and the intestinal flora in the etiology of large bowel cancer. Internatl Symposium on Colorectal Cancer, (Abstr), New York, 1979
Goldin BR, Gorbach SL: Diet and its effect on enzymes linked to colon cancer. Digestion 16(3):240–241, 1977 (Abstr)
Reddy BS, Narisawa T, Weisberger JH: Effect of a diet with high levels of protein and fat on colon carcinogenesis in F344 rats treated with 1,2-Dimethylhydrazine. J Natl Cancer Inst 57:567–569, 1976
Reddy BS, Narisawa T, Wright P, Yukusich D, Weisburger JH, Wynder EL: Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res 35:287–290, 1975
Goldin BR, Gorbach SL: Effect ofLactobacillus acidophilus dietary supplements on 1,2-Dimethylhydrazine dihydrochloride induced intestinal cancer in rats. J Natl Cancer Inst 64:263–265, 1980
Reddy BS, Watanabe K: Effect of intestinal microflora on 3,2′-dimethyl-4-aminobiphenyl-induced carcinogenesis in F344 rats. J Natl Cancer Inst 61:1269–1271, 1978
Reddy BS, Ohmori T: Effect of intestinal microflora and dietary fat on 3,2′-dimethyl-4-aminobiphenyl-induced colon carcinogenesis in F344 rats. Cancer Res 41:1363–1367, 1981
Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL: Effect of diet and Lactobacillus supplements on human fecal bacterial enzymes. J Natl Cancer Inst 64:255–262, 1980
Goldin BR, Gorbach SL: Effect of antibiotics on incidence of rat intestinal tumors induced by 1,2-Dimethylhydrazine Dihydrochloride. J Natl Cancer Inst 67:877–880, 1981
Takada H, Hirook T, Hiramatsu Y, Yamamato M: Effect of beta-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res 42:331–334, 1982
Report from the International Agency for Research on Cancer Intestinal Microecology Group: Dietary fibre, transit-time, fecal bacteria, steroids and colon cancer in two Scandinavian populations. Lancet ii:207–211, 1977
Goldin BR, Gorbach SL: Alterations in fecal microflora enzymes related to diet, age, Lactobacillus supplements, and dimethylhydrazine. Cancer 40:2421–2426, 1977
Bruce WR, Dion PW: Studies relating to fecal mutagen. Am J Clin Nutrition 33:2511–2512, 1980
Bruce WR, Varghese AJ, Furrer A, Land PC: A mutagen in the feces of normal humans.
Kuhnlein U, Bergstrom D, Kuhnlein H: Mutagens in feces from vegetarians and non-vegetarians. Mutation Res 85:1–12, 1981
Mower HF, Ichinotsubo D, Wang LW, Mandel M, Stemmermann G, Nomura A, Heilbrun L, Kamiyama S, Shimada A: Fecal mutagens in two Japanese populations with different colon cancer risks. Cancer Res 42:1164–1169, 1982
Van Tassel RL, MacDonald DK, Wilkins TD: Production of a fecal mutagen byBacteroides spp. Infect Immun 37:975–980, 1982
Hirai N, Kingston GI, Van Tassell RL, Wilkins TD: Structure elucidation of a potent mutagen from human feces. J Amer Chem Soc 104:6150–6154, 1982
Adlercreutz H, Martin F: Oestrogen in human pregnancy faeces. Acta Endocrinologica 83:410–419, 1976
Lombardi P, Goldin B, Boutin E, Gorbach SL: Metabolism of androgens and estrogens by human fecal microorganisms. J Steroid Biochem 9:795–801, 1978
Sandberg AA, Slaunwhite Jr, WR: Studies on phenolic steroids in human subjects. VII. Metabolic fate of estriol and its glucuronide. J Clin Invest 44:694–702, 1965
Inoue N, Sandberg AA, Graham JB, Slaunwhite Jr, WR: Studies on phenolic steroids in human subjects. IX. Role of the intestine in the conjugation of estriol. J Clin Invest 48:390–396, 1969
Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dyer JT, Swenson L, Woods MN: Estrogen excretion patterns and plasma level in vegetarian and omnivorous women. N Engl J Med 307:1542–1547, 1982
Adlercreutz H, Martin F, Tikkanen MJ, Pulkkinen M: Effect of ampicillin administration on the excretion of twelve oestrogens in pregnancy urine. Acta Endocrinologica 80:551–557, 1975
Pulkkinen MO, Willman K: Maternal estrogen levels during penicillin treatment. Br Med J 4:48, 1971
Pulkkinen MO, Willman K: Reduction of maternal estrogen excretion by neomycin. Am J Ob Gyn 115:1153, 1973
Adlercreutz H, Martin F, Lehtinen T, Tikkanen MJ, Pulkkinen MO: Effect of ampicillin administration on plasma conjugated and unconjugated estrogen and progesterone levels in pregnancy. Am J Obstet Gynecol 128:266–271, 1977
Martin F, Peltonen J, Laatikainen T, Pulkkinen M, Adlercreutz H: Excretion of progesterone metabolites and estriol in faeces from pregnant women during ampicillin administration. J Steroid Biochem 6:1339–1346, 1975
Martin F, Bhargava AS, Adlercreutz H: Androgen metabolism in the beagle: Endogenous C 19 0 2 metabolites in bile and faeces and the effect of ampicillin administration. J Steroid Biochem 8:753–760, 1977
Dossetar J: Drug interaction with oral contraceptives. Br Med J 4:467–468, 1975
Author information
Authors and Affiliations
Additional information
Contribution from the Department of Medicine, The George Washington University Medical Center, and The Department of Community Health, Tufts University School of Medicine.
Rights and permissions
About this article
Cite this article
Simon, G.L., Gorbach, S.L. The human intestinal microflora. Digest Dis Sci 31 (Suppl 9), 147–162 (1986). https://doi.org/10.1007/BF01295996
Issue Date:
DOI: https://doi.org/10.1007/BF01295996